Multiples Private Equity-led consortium invests Rs 6,850 M in BDR Pharma
17 May 2022 | News
The funds will be used by the company to build additional research and development capabilities in current and emerging areas
Image Credit: Shutterstock
Multiples Private Equity will lead an investment of Rs 6,850 million, along with a few other marquee financial investors, for a ~9.3 per cent stake in BDR Pharmaceuticals International. Multiples is the first private equity (PE) investor in BDR Pharma.
The consortium of investors participating along with Multiples include institutional investors such as the investment arm of Times Group, QRG Invest (Havells Family Office), and high networth individuals Nishant Agarwal of Avighna Group, and Mallika Srinivasan of TAFE.
The funds will be used by the company to build additional research and development capabilities in current and emerging areas, accelerate investments in manufacturing capacity expansion and enhance the degree of vertical integration. The company will also selectively pursue inorganic opportunities to build scale.
